Camouflaging endothelial cells: Does it prolong graft survival?

Biochimica et Biophysica Acta - General Subjects

Volumn 1428, Issue 2-3, 1999, Pages 177-190

  Stuhlmeier, Karl M ^a   Lin, Yuan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement binding; Endothelial cell; Immunoglobulin binding; Organ rejection

Indexed keywords

CELL ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MACROGOL DERIVATIVE; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT SURVIVAL; GUINEA PIG; HAMSTER; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE; XENOGRAFT;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; COMPLEMENT C3; CRICETINAE; E-SELECTIN; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MALE; MESOCRICETUS; NF-KAPPA B; PERFUSION; POLYETHYLENE GLYCOLS; RATS; SWINE; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032791196     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00065-3     Document Type: Article

References (39)

1. S.T. Jeong, S.M. Byun, Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells: Significance as a blood substitute, Artif. Cells Blood Substit. Immobil. Biotechnol. 5 (1996) 503-511.
2. J.K. Armstrong, H.J. Meiselman, T.C. Fisher, Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity, Am. J. Hematol. 56 (1997) 26-28.
3. M.D. Scott, K.L. Murad, F. Koumpouras, M. Talbot, J.W. Eaton, Chemical camouflage of antigenic determinants - stealth erythrocytes, Proc. Natl. Acad. Sci. USA 94 (1997) 7566-7571.
4. Y. Inada, M. Furukawa, H. Sasaki, Biomedical and biotechnological applications of PEG- and PM-modified proteins, Trends Biotechnol. 13 (1995) 86-91.
5. S.M. Foroutan, D.G. Watson, Synthesis and characterisation of polyethylene glycol conjugates of hydrocortisone as potential prodrugs for ocular steroid delivery, Int. J. Pharm. 157 (1997) 103-111.
6. K.D. Park, Y.S. Kim, D.K. Han, Y.H. Kim, E. Lee, H. Suh, K.S. Choi, Bacterial adhesion on PEG modified polyurethane surfaces, Biomaterials 19 (1998) 851-859.
7. M. Sugimoto, T. Okagaki, S. Narisawa, Y. Koida, K. Nakajima, Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer, Int. J. Pharm. 160 (1998) 11-19.
8. H. Bentz, J.A. Schroeder, T.D. Estridge, Improved local delivery of TGF-beta-2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol, J. Biomed. Mater. Res. 39 (1998) 539-548.
9. J.S. Beckman, R.J. Minor, C.W. White, J.E. Repine, G.M. Rosen, B.A. Freeman, Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance, J. Biol. Chem. 14 (1988) 6884-6892.
10. P. Westermann, T. Glanzmann, S. Andrejevic, D.R. Braichotte, M. Forrer, G.A. Wagnieres, P. Monnier, H. Vandenbergh, J.P. Mach, S. Folli, Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma, Int. J. Cancer 76 (1998) 842-850.
11. Y.Y. Tan, X.H. Sun, M.X. Xu, Z.L. An, X.Z. Tan, X.Y. Tan, Q.H. Han, D.A. Miljkovic, M. Yang, R.M. Hoffman, Polyethylene glycol conjugation of recombinant methioninase for cancer therapy, Protein Express. Purif. 12 (1998) 45-52.
12. C.L. Vandenberg, G.N. Cox, C.A. Stroh, S.G. Hilsenbeck, C.N. Weng, M.J. Mcdermott, D. Pratt, C.K. Osborne, E.B. Coronadoheinsohn, D. Yee, Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFbp-1) inhibits growth of breast cancer in athymic mice, Eur. J. Cancer 33 (1997) 1108-1113.
13. K.H. George, Stealthy blood cells manage to survive xenotransfusion, J. NIH Res. 9 (1997) 26-28.
14. T. Miyatake, K. Sato, K. Takigami, Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection, J. Immunol. 160 (1998) 4114-4123.
15. F. Sanfilippo, W.M. Baldwin, Antibody and complement in graft rejection, Transplant. Proc. 1997 (1997) 1-2.
16. R. Pierson, K.W. Kasper, D.N. Tew, Hyperacute lung rejection in a pig-to-human transplant model : the role of anti-pig antibody and complement, Transplantation 63 (1997) 594-603.
17. K.M. Stuhlmeier, V. Csizmadia, Q. Cheng, H. Winkler, F.H. Bach, Selective inhibition of E-selectin, ICAM-1, and VCAM in endothelial cells, Eur. J. Immunol. 24 (1994) 2186-2190.
18. F. Denizot, R. Lang, Rapid colorimetic assay for cell growth and survival, J. Immunol. Methods 89 (1986) 271-277.
19. K.M. Stuhlmeier, H. Winkler, V. Csizmadia, Q. Cheng, F.H. Bach, Selective inhibition of E-selectin expression by alpha-globulins, Transplant. Proc. 26 (1994) 1321.
20. K.M. Stuhlmeier, C. Tarn, F.H. Bach, The effect of 5,8,11,14-eicosatetraynoic acid on endothelial cell gene expression, Eur. J. Pharmacol. 325 (1997) 209-219.
21. K.M. Stuhlmeier, J.J. Kao, F.H. Bach, Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaB-alpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB, J. Biol. Chem. 272 (1997) 24679-24683.
22. Y. Lin, P. Ji, G. Xia, M. Vandeputte, M. Waer, Blockade of induced xenoantigen expression prevents rejection after retransplantation of accommodated hamster-to-rat heart xenograft, Transplantation 65 (1998) 340-345.
23. Y. Lin, M. Vandeputte, M. Waer, Factors involved in rejection of concordant xenografts in complement-deficient rats., Transplantation 63 (1997) 1705-1712.
24. F.H. Bach, S.C. Robson, C. Ferran, H. Winkler, M.T. Millan, K.M. Stuhlmeier, B. Vanhove, M.L. Blakely, W.J. van der Werf, E. Hofer et al., Endothelial cell activation and thromboregulation during xenograft rejection, Immunol. Rev. 141 (1994) 5-30.
25. F.H. Bach, M.L. Blakely, W.J. Van der Werf, B. Vanhove, K. Stuhlmeier, M.R. de, H. Winkler, Xenotransplantation: problems posed by endothelial cell activation, Transplant. Proc. 26 (1994) 1029-1030.
26. F.H. Bach, S.C. Robson, H. Winkler, C. Ferran, K.M. Stuhlmeier, C.J. Wrighton, W.W. Hancock, Barriers to xenotransplantation, Nature Med. 1 (1995) 869-873.
27. S.N. McGill, N.A. Ahmed, N.V. Christou, Endothelial cells: role in infection and inflammation, World J. Surg. 22 (1998) 171-178.
28. A.B. Malik, S.K. Lo, Vascular endothelial adhesion molecules and tissue inflammation, Pharmacol. Rev. 48 (1996) 213-229.
29. S.C. Robson, D. Candinas, W.W. Hancock, C. Wrighton, H. Winkler, F.H. Bach, Role of endothelial cells in transplantation, Int. Arch. Allergy Immunol. 106 (1995) 305-322.
30. M.A. Read, M.Z. Whitley, S. Gupta, Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways, J. Biol. Chem. 272 (1997) 2753-2761.
31. T. Collins, M.A. Read, A.S. Neish, M.Z. Whithley, D. Thanos, T. Maniatis, Transcriptional regulation of endothelial cell adhesion molecules: NF-kappaB and cytokine-inducible enhancers, FASEB J. 9 (1995) 899-909.
32. U. Siebenlist, K. Brown, G. Franzoso, in: P.A. Bauerle (Ed.), Inducible Gene Expression, Vol. 1, Birkhäuser, Boston, MA, 1995, pp. 93-141.
33. F.H. Bach, H. Winkler, C.J. Wrighton, S.C. Robson, K. Stuhlmeier, C. Ferran, Xenotransplantation : a possible solution to the shortage of donor organs, Transplant. Proc. 28 (1996) 416-417.
34. C. Delgado, J.N. Patel, G.E. Francis, D. Fisher, Coupling of polyethylene glycol to albumin under very mild conditions by activation with tresyl chloride: characterization of the conjugate by partitioning in aqueous two-phase systems, Biotechnol. Appl. Biochem. 12 (1990) 119-128.
35. A. Gabizon, F. Martin, Polyethylene glycol coated (pegylated) liposomal doxorubicin - rationale for use in solid tumours, Drugs 54 (1997) 15-21.
36. N. Koyamada, T. Miyatake, D. Candinas, W. Mark, P. Hechenleitner, W. Hancock, M. Soares, F.H. Bach, Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts, Transplantation 65 (1998) 1210-1215.
37. J.R. Leventhal, A.J. Matas, L.H. Sun, S. Reif, R. Bolman, A.P. Dalmasso, P. J.L., The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model, Transplantation 56 (1993) 1-8.
38. F.H. Bach, K.M. Stuhlmeier, B. Vanhove, W.J. Van der Werf, M.L. Blakely, M.R. de, W.W. Hancock, H. Winkler, Endothelial cells in xenotransplantation : do they accommodate? Transplant. Proc. 26 (1994) 1167-1169.
39. C.R. Deible, E.J. Beckman, A.J. Russell, W.R. Wagner, Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol, J. Biomed. Mater. Res. 41 (1998) 251-256.